Breath Diagnostics, Inc. Employee Directory
Biotechnology ResearchKentucky, United States2-10 Employees
Breath Diagnostics, Inc. operates in the biotechnology research space with a focus on non-invasive lung cancer detection. The company has developed a patented breath-analysis approach that aims to determine whether a patient has lung cancer by analyzing exhaled breath with parts-per-billion accuracy, enabling very early detection. The technology has been studied in more than 800 patients, highlighting its potential to influence diagnostic pathways. Based in Louisville, Kentucky, the company comprises a small, specialized team within the biotechnology research sector. In late October 2024, Breath Diagnostics announced the appointment of Aaron Roebuck as President. The company appears to target healthcare providers and patients seeking early, non-invasive screening for lung cancer, addressing the need for accurate, minimally invasive diagnostic options.